Details for New Drug Application (NDA): 018389
✉ Email this page to a colleague
The generic ingredient in ALDOMET is methyldopa. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyldopa profile page.
Summary for 018389
Tradename: | ALDOMET |
Applicant: | Merck |
Ingredient: | methyldopa |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018389
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 250MG/5ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 018389
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | ALDOMET | methyldopa | SUSPENSION;ORAL | 018389-001 | Approved Prior to Jan 1, 1982 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription